tiprankstipranks
Scinai Immunotherapeutics Amends Shareholder Terms
Company Announcements

Scinai Immunotherapeutics Amends Shareholder Terms

Scinai Immunotherapeutics (SCNI) has released an update.

Don't Miss our Black Friday Offers:

Scinai Immunotherapeutics Ltd. has announced amendments to its articles of association to permit the creation and issuance of preferred shares as part of a debt-to-equity conversion deal with the European Investment Bank. The changes include a revised limit on shareholder ownership post-conversion and updated terms for converting preferred shares into ordinary shares. The company is set to hold an Extraordinary General Meeting on August 12, 2024, for shareholders to vote on these proposals.

For further insights into SCNI stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskScinai Immunotherapeutics Reports Financial Turnaround and Growth
TipRanks Auto-Generated NewsdeskScinai Immunotherapeutics Gains Shareholder Confidence
TipRanks Auto-Generated NewsdeskScinai Immunotherapeutics to Hold Annual Shareholder Meeting
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App